Pledges tied to India — folded into a wider tally of domestic and overseas capital commitments — reached $330.5 billion according to figures released by the White House. Dated October 16, 2026, the disclosure points to a broader foothold that Indian-owned enterprises have built across American sectors spanning energy, steel, pharmaceuticals, and advanced manufacturing.
The footage, compiled to highlight those investments, was published on the administration's YouTube channel and subsequently distributed across its other social media platforms. Two line items covering India appeared in the presentation — one carrying a valuation of $310 billion and a second at $20.5 billion — with those figures adding up to a combined total of $330.5 billion.
On 16 October 2026, an investment presentation released by the White House laid out the breadth of financial pledges tied to domestic corporations, overseas enterprises, and foreign governments. Sectors covered in the document ranged from energy and steel through pharmaceuticals and semiconductors to artificial intelligence, infrastructure, and advanced manufacturing, with capital commitments noted across each. Broadening domestic manufacturing and drawing in new investment formed a strand of what the administration was pursuing at the time.
Two separate line items attributed to India appeared in the presentation — one carrying a figure of $310 billion and another of $20.5 billion, bringing the combined amount recorded for that country to $330.5 billion. Drawn from both domestic and overseas contributors, the wider package of pledges and investment commitments reached a combined figure of roughly $10.871 trillion.
A formal ledger of corporate undertakings, overseas investment pledges, and industrial expansion activity is kept by the White House as part of its official record-keeping. Among the entries documented in the register are several ventures with ties to India, among them projects connected to Reliance-affiliated operations and the Essar-backed enterprise Mesabi Metallics.
Among the planned ventures drawing on Indian corporate backing are a refinery project in Texas linked to Reliance Industries, operating under the America First Refining name, alongside a steel production facility put forward by Mesabi Metallics, a company supported by the Essar group. Among the entries carrying ties to India, a planned petroleum-processing facility in Brownsville, Texas — put forward through America First Refining and linked to Reliance Industries — stands out as one of the more substantial items on the list.
A $300 billion pledge tied to refinery development was put forward by the White House in March 2026, framed as one element of a broader push to build out domestic energy infrastructure and petroleum refining capacity. A figure of $300 billion was attached to the refinery-linked programme outlined in the White House's public statement.
Backed by Essar, Mesabi Metallics put forward a plan on 29 September 2026 to channel $18 billion into building out a fully integrated steel-making operation across the United States. Rolled out during a White House event in Washington, DC, the deal sits within a broader corporate push toward building a fully integrated steel production chain. Spread across two states, the plan channels roughly $3 billion toward iron ore extraction and pelletisation work the company already runs in Nashwauk, Minnesota, while earmarking a further $15 billion for a steel-production facility proposed for Iowa. Essar's own release put the Iowa development's workforce footprint at upwards of 8,000 positions tied to the construction phase.
Pledges of considerable capital directed toward facilities and research programmes on American soil have come from drug manufacturers based in India, extending their footprint across both production and scientific development. At the SelectUSA Investment Summit convened in Maryland between 3 and 6 May 2026, companies based in India put forward pledges covering a combined $20.5 billion in planned investment. A factsheet published by the embassy on May 6, 2026, set out the details of those pledges in an official document.
Pledges tied to the pharmaceutical sector alone topped $19.1 billion of the total commitments put forward. Among the Indian pharmaceutical firms that took part were Sun Pharmaceutical Industries, Aurobindo Pharma, Biocon, Cipla, Dr Reddy's Laboratories, Glenmark Pharmaceuticals, Granules India, Jubilant Group, Lupin, Piramal Pharma, and Zydus Lifesciences — eleven companies in total whose domestic operations span generics, biologics, and contract manufacturing across the sector. Among the notable items was a plan put forward by Sun Pharmaceutical Industries to take over Organon & Co, the New Jersey-headquartered drugmaker, in a deal valued at $11.75 billion.
Over $56 billion in fresh and planned investment pledges from overseas businesses attending the 2026 SelectUSA Investment Summit were recorded by the Commerce Department.
Those totals cover pledged funding, projected spending, and formal financial obligations tied to initiatives at varying points along the development pipeline. Listing items in the White House document does not guarantee that every dollar of that total has already been deployed. Listed separately within the administration's investment tracking portal, a $500 billion entry tied to India reflects trade expansion objectives and falls under a distinct classification of economic commitment from others recorded there.
